MedTrace Logo

Project: Every Child for Younger Patients With Cancer

NCT02402244 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75000

Last updated 2026-05-05

No results posted yet for this study

Summary

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Conditions

  • Adrenal Gland Pheochromocytoma
  • Carcinoma In Situ
  • Central Nervous System Neoplasm
  • Childhood Immature Teratoma
  • Childhood Kidney Neoplasm
  • Childhood Langerhans Cell Histiocytosis
  • Childhood Mature Teratoma
  • Congenital Mesoblastic Nephroma
  • Desmoid Fibromatosis
  • Ganglioneuroma
  • Lymphoproliferative Disorder
  • Malignant Neoplasm
  • Malignant Solid Neoplasm
  • Melanocytic Neoplasm
  • Myeloproliferative Neoplasm
  • Neoplasm of Uncertain Malignant Potential
  • Neuroendocrine Neoplasm
  • Stromal Neoplasm

Interventions

OTHER

Cytology Specimen Collection Procedure

Undergo cytology specimen collection

OTHER

Medical Chart Review

Undergo medical data review

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Douglas S Hawkins · Children's Oncology Group

Eligibility

Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-03
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • United States
  • Australia
  • Canada
  • New Zealand
  • Puerto Rico
  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02402244 on ClinicalTrials.gov